Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa

Journal of Clinical Microbiology

Volumn 50, Issue 4, 2012, Pages 1189-1194

  Dorman, Susan E ^a   Chihot, Violet N ^b   Lewis, James J ^b,c   Van Meulen, Minty Der ^b   Mathem, Barun ^d   Beylis, Natalie ^e   Fielding, Katherine L ^c   Grant, Alison D ^c   Churchyard, Gavin J ^b,c  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b AURUM INSTITUTE   (South Africa)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d PUBLIC HEALTH RESEARCH INSTITUTE   (United States)

^e NATIONAL HEALTH LABORATORY SERVICE   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; RIFAMPICIN;

ACCURACY; ADULT; ANALYTICAL EQUIPMENT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIUM CULTURE; BACTERIUM DETECTION; BACTERIUM EXAMINATION; BACTERIUM IDENTIFICATION; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; GENETIC PROCEDURES; GOLDMINER; HUMAN; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MINER; MINING; MOLECULAR PROBE; MYCOBACTERIAL GROWTH INDICATOR TUBE CULTURE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SOUTH AFRICA; SPUTUM CULTURE; SPUTUM CYTODIAGNOSIS;

ADULT; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; CROSS-SECTIONAL STUDIES; FEMALE; GENOTYPE; GOLD; HUMANS; ISONIAZID; MALE; MIDDLE AGED; MINING; MOLECULAR DIAGNOSTIC TECHNIQUES; MULTIPLEX POLYMERASE CHAIN REACTION; MYCOBACTERIUM TUBERCULOSIS; RIFAMPIN; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; SOUTH AFRICA; SPUTUM; TUBERCULOSIS, MULTIDRUG-RESISTANT; TUBERCULOSIS, PULMONARY;

MYCOBACTERIUM TUBERCULOSIS;

EID: 84863411580     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.05723-11     Document Type: Article

References (33)

1. Anek-Vorapong R, et al. 2010. Validation of the GenoType MTBDRplus assay for detection of MDR-TB in a public health laboratory in Thailand. BMC Infect. Dis. 10:123.
2. Bang D, Bengård Andersen A, Thomsen VØ. 2006. Rapid genotypic detection of rifampin-and isoniazid-resistant Mycobacterium tuberculosis directly in clinical specimens. J. Clin. Microbiol. 44:2605-2608. (Pubitemid 44092440)
3. Barnard M, Albert H, Coetzee G, O'Brien R, Bosman ME. 2008. Rapid molecular screening for multidrug-resistant tuberculosis in a high-volume public health laboratory in South Africa. Am. J. Respir. Crit. Care Med. 177:787-792. (Pubitemid 351490566)
4. Boehme CC, et al. 2010. Rapid molecular detection of tuberculosis and rifampin resistance. N. Engl. J. Med. 363:1005-1015.
5. Bwanga F, Joloba ML, Haile M, Hoffner S. 2010. Evaluation of seven tests for the rapid detection of multidrug-resistant tuberculosis in Uganda. Int. J. Tuberc. Lung Dis. 14:890-895.
6. Calver AD, et al. 2010. Emergence of increased resistance and extensively drug-resistant tuberculosis despite treatment adherence, South Africa. Emerg. Infect. Dis. 16:264-271.
7. Chien HP, Yu MC, Wu MH, Lin TP, Luh KT. 2000. Comparison of the BACTEC MGIT 960 with Löwenstein-Jensen medium for recovery of mycobacteria from clinical specimens. Int. J. Tuberc. Lung Dis. 4:866-870.
8. Chihota VN, et al. 2010. Liquid vs. solid culture for tuberculosis: performance and cost in a resource-constrained setting. Int. J. Tuberc. Lung Dis. 14:1024-1031.
9. Churchyard GJ, et al. 2010. Symptom and chest radiographic screening for infectious tuberculosis prior to starting isoniazid preventive therapy: yield and proportion missed at screening. AIDS 24(Suppl. 5):S19-S27.
10. Corbett EL, et al. 2002. Morbidity and mortality in South African gold miners: impact of untreated disease due to human immunodeficiency virus. Clin. Infect. Dis. 34:1251-1258. (Pubitemid 34450674)
11. Dowdy DW, et al. 2008. Impact and cost-effectiveness of culture for diagnosis of tuberculosis in HIV-infected Brazilian adults. PLoS One 3:e4057.
12. Fielding KL, et al. 2011. Thibela TB: Design and methods or a cluster randomised trial of the effect of community-wide isoniazid preventive therapy on tuberculosis among gold miners in South Africa. Contemp Clin. Trials 32:382-392.
13. Hain Lifescience GmbH. GenoType MTBDRplus 1.0 product insert. Hain Lifescience GmbH, Nehren, Germany. http://www.hain-lifescience.com.
14. Hillemann D, Rüsch-Gerdes S, Richter E. 2006. Application of the GenoType MTBDR assay directly on sputum specimens. Int. J. Tuberc. Lung Dis. 10:1057-1059. (Pubitemid 44378986)
15. Hillemann D, Rüsch-Gerdes S, Richter E. 2007. Evaluation of the Geno-Type MTBDRplus assay for rifampin and isoniazid susceptibility testing of Mycobacterium tuberculosis strains and clinical specimens. J. Clin. Microbiol. 45:2635-2640. (Pubitemid 47295497)
16. Idigoras P, Beristain X, Iturzaeta A, Vicente D, Perez-Trallero E. 2000. Comparison of the automated nonradiometric Bactec MGIT 960 system with Lowenstein-Jensen Coletsos and Middlebrook 7H11 solid media for recovery of mycobacteria. Eur. J. Clin. Microbiol. Infect. Dis. 19:350-354. (Pubitemid 30389378)
17. Kent PT, Kubica GP. 1985. Public health mycobacteriology: a guide for the level III laboratory. Centers for Disease Control, Atlanta, GA.
18. Lewis JJ, et al. 2009. HIV infection does not affect active case finding of tuberculosis in South African gold miners. Am. J. Respir. Crit. Care Med. 180:1271-1278.
19. Ling D, Zwerling A, Pai M. 2008. GenoType MTBDR assays for the diagnosis of multidrug-resistant tuberculosis: a meta-analysis. Eur. Respir. J. 32:1165-1174.
20. Miotto P, Piana F, Cirillo DM, Migliori GB. 2008. Genotype MTBDRplus: a further step toward rapid identification of drug-resistant Mycobacterium tuberculosis. J. Clin. Microbiol. 46:393-394.
21. Mironova S, et al. 25 October 2011. Performance of the GenoType MTBDRplus assay in routine settings: a multicenter study. Eur. J. Clin. Microbiol. Infect. Dis. [Epub ahead of print.]
22. Muyoyeta M, et al. 2009. Comparison of four culture systems for Myco- bacterium tuberculosis in the Zambian National Reference Laboratory. Int. J. Tuberc. Lung Dis. 13:460-465.
23. Narvaiz de Kantor I, et al. 1998. Laboratory services in TB control: microscopy, part II. WHO/TB/98.258. World Health Organization, Geneva, Switzerland. http://wwwn.cdc.gov/dls/ILA/documents/lstc2.pdf.
24. Nikolayevskyy V, et al. 2009. Performance of the Genotype MTBDRPlus assay in the diagnosis of tuberculosis and drug resistance in Samara, Russian Federation. BMC Clin. Pathol. 9:2.
25. Otu J, et al. 2008. Comparative evaluation of BACTEC MGIT 960 with BACTEC 9000 MB and LJ for isolation of mycobacteria in The Gambia. J. Infect. Dev. Ctries. 2:200-205.
26. Parrish N, Dionne K, Sweeney A, Hedgepeth A, Carroll K. 2009. Differences in time to detection and recovery of Mycobacterium spp. between the MGIT 960 and the BacT/ALERT MB automated culture systems. Diagn. Microbiol. Infect. Dis. 63:342-345.
27. Ramaswamy S, Musser JM. 1998. Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update. Tuber Lung Dis. 79:3-29. (Pubitemid 29050434)
28. Rigouts L, et al. 2011. Evaluation of the Genotype MTBDRplus assay as a tool for drug resistance surveys. Int. J. Tuberc. Lung Dis. 15:959-965.
29. Verweij KE, et al. 2010. Application of modern microbiological diagnostic methods for tuberculosis in Macha, Zambia. Int. J. Tuberc. Lung Dis. 14:1127-1131.
30. Williams-Bouyer N, Yorke R, Lee HI, Woods GL. 2000. Comparison of the BACTEC MGIT 960 and ESP culture system II for growth and detection of mycobacteria. J. Clin. Microbiol. 38:4167-4170. (Pubitemid 32233221)
31. World Health Organization. 2008. Policy statement. Molecular line probe assays for rapid screening of patients at risk of multidrug-resistant tuberculosis (MDR-TB). World Health Organization, Geneva, Switzerland. http://www.who.int/tb/features-archive/policy-statement.pdf. Accessed 8 January 2011.
32. World Health Organization. 2010. The global plan to stop TB 2011-2015: transforming the fight towards elimination of tuberculosis. World Health Organization, Geneva, Switzerland. http://www.stoptb.org/assets/documents/ global/plan/TB-GlobalPlanToStopTB2011-2015.pdf. Accessed 8 January 2011.
33. World Health Organization. 2009. 62nd World Health Assembly. WHA62/2009/REC/1. World Health Organization, Geneva, Switzerland. http://apps.who.int/gb/ebwha/pdf-files/WHA62-REC1-en-P1.pdf.